Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)

ClinicalTrials.gov ID: NCT03556202

Public ClinicalTrials.gov record NCT03556202. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 4:43 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the long-term safety and maintenance of efficacy of mirikizumab in participants with moderate-to-severe plaque psoriasis.

Study identification

NCT ID
NCT03556202
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
1,936 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 3, 2018 (Actual)
Primary completion
Feb 7, 2022 (Actual)
Completion
Feb 7, 2022 (Actual)
Last update posted
Mar 21, 2023

2018 – 2022

United States locations

U.S. sites
47
U.S. states
24
U.S. cities
44
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35233 —
Zenith Research, Inc. Beverly Hills California 90212 —
California Dermatology & Clinical Research Institute Encinitas California 92024 —
First OC Dermatology Fountain Valley California 92708 —
Keck School of Medicine University of Southern California Los Angeles California 90033 —
Dermatology Clinical Trials Newport Beach California 92660-7831 —
San Luis Dermatology & Laser Clinic San Luis Obispo California 93405 —
Clinical Science Institute Santa Monica California 90404 —
Univ of Connecticut Farmington Connecticut 06030-2840 —
Florida Academic Centers Research and Education, LLC Coral Gables Florida 33134 —
Renstar Medical Research Ocala Florida 34470 —
Park Avenue Dermatology Orange Park Florida 32073 —
ForCare Clinical Research Tampa Florida 33613-1244 —
Dermatologic Surgery Specialists, PC Macon Georgia 31217 —
Meridian Clinical Research Savannah Georgia 31406 —
Advanced Clinical Research LLC Meridian Idaho 83642 —
University Dermatology Darien Illinois 60561 —
Arlington Dermatology Rolling Meadows Illinois 60008 —
Dawes Fretzin Clinical Research Group, LLC Indianapolis Indiana 46250 —
The Indiana Clinical Trials Center Plainfield Indiana 46168 —
The South Bend Clinic Center for Research South Bend Indiana 46617 —
Forefront Research Louisville Kentucky 40241 —
DelRicht Research Baton Rouge Louisiana 70809 —
Dermatology and Skin Cancer Specialists Rockville Maryland 20850 —
Lawrence J Green, M.D, LLC Rockville Maryland 20850 —
ORA, Inc Andover Massachusetts 01810 —
Central Dermatology PC St Louis Missouri 63117 —
Psoriasis Treatment Center of Central New Jersey East Windsor New Jersey 08520 —
Mount Sinai School of Medicine Dermatology Clinical Trials New York New York 10029 —
PMG Research of Cary, LLC Cary North Carolina 27518 —
University of North Carolina Dermatology and Skin Cancer Cen Chapel Hill North Carolina 27516 —
PMG Research of Wilmington Wilmington North Carolina 28411 —
Bexley Dermatology Research Bexley Ohio 43209 —
University Hospitals Cleveland Medical Center Cleveland Ohio 44106 —
Wright State Univ School of Medicine Fairborn Ohio 45324 —
Oregon Dermatology and Research Center Portland Oregon 97210 —
Oregon Medical Research Center Portland Oregon 97223 —
Oregon Health and Science University Portland Oregon 97239 —
The Pennsylvania Centre for Dermatology, LLC Exton Pennsylvania 19341 —
Clinical Partners, LLC Johnston Rhode Island 02919 —
Modern Research Associates Dallas Texas 75231 —
Austin Institute for Clinical Research Pflugerville Texas 78660 —
Texas Dermatology and Laser Specialists San Antonio Texas 78218 —
University of Utah Murray Utah 84107 —
Virginia Clinical Research, Inc. Norfolk Virginia 23502 —
Dermatology Associates Seattle Washington 98101 —
MultiCare Good Samaritan Hospital Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 182 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03556202, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 21, 2023 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03556202 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →